Soumit Roy

Stock Analyst at Jones Trading

(1.50)
# 3,361
Out of 4,893 analysts
42
Total ratings
18.75%
Success rate
-6.21%
Average return

Stocks Rated by Soumit Roy

Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $3.12
Upside: +573.08%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $22.00
Upside: +81.82%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36$27
Current: $22.75
Upside: +18.68%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.35
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.12
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.48
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $7.21
Upside: +108.04%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $22.03
Upside: +54.34%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.29
Upside: +1,472.05%
Initiates: Buy
Price Target: $32
Current: $2.55
Upside: +1,154.90%
Downgrades: Hold
Price Target: n/a
Current: $1.73
Upside: -
Initiates: Buy
Price Target: $9
Current: $8.37
Upside: +7.59%
Initiates: Buy
Price Target: $17
Current: $11.45
Upside: +48.47%
Initiates: Buy
Price Target: $13
Current: $3.06
Upside: +324.84%
Maintains: Buy
Price Target: $6$4
Current: $0.74
Upside: +440.69%
Downgrades: Hold
Price Target: n/a
Current: $2.16
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $6.31
Upside: -
Maintains: Buy
Price Target: $22$26
Current: $7.84
Upside: +231.84%
Initiates: Buy
Price Target: $70
Current: $25.61
Upside: +173.33%
Upgrades: Buy
Price Target: $10
Current: $38.26
Upside: -73.86%
Downgrades: Hold
Price Target: n/a
Current: $3.49
Upside: -
Initiates: Buy
Price Target: $80
Current: $9.50
Upside: +742.11%
Downgrades: Hold
Price Target: n/a
Current: $2.00
Upside: -
Initiates: Buy
Price Target: $320
Current: $4.48
Upside: +7,042.86%
Initiates: Buy
Price Target: $810
Current: $4.83
Upside: +16,670.19%